| P2093 | author name string | Kevin Moore | |
| | Mark Elliott | |
| | Bryony Gray | |
| | Matthew Beard | |
| | Imran Mir | |
| | Fraser Hornby | |
| | David Burgin | |
| | Gavin Hackett | |
| P2860 | cites work | Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1. | Q51505838 |
| | Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A. | Q54541506 |
| | Expression and Purification of the Light Chain of Botulinum Neurotoxin A: A Single Mutation Abolishes Its Cleavage of SNAP-25 and Neurotoxicity after Reconstitution with the Heavy Chain | Q54599905 |
| | The N-terminal half of the receptor domain of botulinum neurotoxin A binds to microdomains of the plasma membrane | Q61662145 |
| | Botulinum neurotoxin type A: sequence of amino acids at the N-terminus and around the nicking site | Q68375457 |
| | Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease | Q69521812 |
| | Regulation of neurotoxin complex expression in Clostridium botulinum strains 62A, Hall A-hyper, and NCTC 2916 | Q83345968 |
| | Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity | Q85651745 |
| | Validity of botulinum neurotoxin serotype H | Q87661789 |
| | Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5 | Q24299963 |
| | Examination of feces and serum for diagnosis of infant botulism in 336 patients | Q24647671 |
| | Glycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype F | Q27655649 |
| | Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B | Q27665891 |
| | Structural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D | Q27677003 |
| | Botulinum Neurotoxin Is Shielded by NTNHA in an Interlocked Complex | Q27677462 |
| | Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A | Q28581589 |
| | Botulinum neurotoxin type A: cleavage of the heavy chain into two halves and their partial sequences | Q28609194 |
| | Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids | Q33308728 |
| | Botulinum neurotoxin D-C uses synaptotagmin I and II as receptors, and human synaptotagmin II is not an effective receptor for type B, D-C and G toxins | Q33793263 |
| | Characteristics of Clostridium botulinum Type F Isolated from the Pacific Coast of the United States | Q33802104 |
| | Structural basis of the pH-dependent assembly of a botulinum neurotoxin complex. | Q34616143 |
| | Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: bont/A2, bont/F4 and bont/F5. | Q34700141 |
| | Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxins. | Q34738054 |
| | Biology and genomic analysis of Clostridium botulinum. | Q34990351 |
| | Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms | Q35188905 |
| | Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A). | Q35910511 |
| | Purification and characterization of a protease from Clostridium botulinum type A that nicks single-chain type A botulinum neurotoxin into the di-chain form | Q36162224 |
| | Unique biological activity of botulinum D/C mosaic neurotoxin in murine species | Q36211139 |
| | Molecular Assembly of Clostridium botulinum progenitor M complex of type E | Q36350322 |
| | Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test | Q36401425 |
| | A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin | Q36440215 |
| | Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain | Q36891334 |
| | Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin | Q36946982 |
| | N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A. | Q37276819 |
| | Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions | Q37700722 |
| | Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H. | Q37727928 |
| | Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering | Q37954285 |
| | Botulinum neurotoxins: genetic, structural and mechanistic insights. | Q38224215 |
| | Historical and current perspectives on Clostridium botulinum diversity | Q38259821 |
| | Simplified purification method for Clostridium botulinum type E toxin | Q39926620 |
| | Mechanism of substrate recognition by the novel Botulinum Neurotoxin subtype F5. | Q40078527 |
| | Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E. | Q40157907 |
| | SV2 is the protein receptor for botulinum neurotoxin A. | Q40303506 |
| | Sequence diversity of genes encoding botulinum neurotoxin type F. | Q41773499 |
| | Purification and characterization of a novel subtype a3 botulinum neurotoxin | Q42151342 |
| | Activation of Clostridium botulinum type E toxin by trypsin | Q42242543 |
| | Structural analysis of Clostridium botulinum neurotoxin type D as a platform for the development of targeted secretion inhibitors | Q42580273 |
| | ADP-ribosylation of 24-26-kDa GTP-binding proteins localized in neuronal and non-neuronal cells by botulinum neurotoxin D. | Q42800222 |
| | Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor | Q43299518 |
| | Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin | Q43469252 |
| | Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin | Q43691688 |
| | Molecular characterization of a novel botulinum neurotoxin type H gene | Q45290850 |
| | A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins | Q45345427 |
| | Separation of toxic activity and ADP-ribosylation activity of botulinum neurotoxin D. | Q46328631 |
| | Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms | Q46880568 |
| | Substrate cleavage and duration of action of botulinum neurotoxin type FA ("H, HA"). | Q47257258 |
| | Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3. | Q47776201 |
| | Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics | Q47783055 |
| | Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin | Q48268335 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P577 | publication date | 2018-05-11 | |
| P1433 | published in | Toxins | Q15724569 |
| P1476 | title | Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H. | |
| P478 | volume | 10 | |